Literature DB >> 33568225

The views of New Zealand general practitioners and patients on a proposed risk assessment and communication tool: a qualitative study using Normalisation Process Theory.

Sharon Leitch1, Alesha Smith2, Sue Crengle3, Tim Stokes3.   

Abstract

BACKGROUND: Communicating risks of medication harm and obtaining informed consent is difficult due to structural barriers, language and cultural practices, bias and a lack of resources appropriately tailored for the health literacy of most patients. A decision support tool was proposed to alert prescribers of risk and provide tailored information for patients to facilitate informed decision-making with patients and their whānau (family) around medication use. Patient and prescriber co-design was used to ensure the tool was designed to best meet the needs of end-users and avoid increasing health inequity. This paper describes the first stage of the co-design process.
METHOD: Normalisation Process Theory (NPT) was used to prospectively evaluate the tool. Semi-structured interviews were held with fifteen patients (five Māori, five Pasifika and five NZ European) and nine general practitioners (two Māori and seven European).
RESULTS: Three themes were identified, which related to the three NPT concepts most relevant to developing the tool. Theme 1 (coherence: meaning and sense making by participants) explored participants' understanding of prescribing safety, medication harm and risk, which is based on experience. Patients want as much information as possible about their medications and risk, but doctors find it difficult to communicate that information. Theme 2 related to the NPT concept of cognitive participation (commitment and engagement by participants) explored what participants thought about a prescribing decision support tool. Participants were cautiously optimistic, but worried about potential harm arising from its use. They also identified requirements for the tool and features to avoid. Theme 3 describes the collective action required for successful implementation of the tool; namely, culturally safe and trustworthy doctor-patient relationships.
CONCLUSION: Patients and general practitioners provided different perspectives when prospectively evaluating the proposed risk assessment and communication tool. This co-design research identified important pre-requisites for the tool and features to avoid and novel ideas for the proposed tool. Overall participants supported the development of the proposed risk assessment and communication tool, but identified the important role that doctor-patient relationships would play to ensure successful implementation. The use of Māori and Pacific languages in the proposed tool may enhance engagement and understanding.

Entities:  

Keywords:  Communication; Equity; General practice; Medication harm; Normalisation Process Theory; Risk

Year:  2021        PMID: 33568225      PMCID: PMC7877107          DOI: 10.1186/s43058-021-00120-1

Source DB:  PubMed          Journal:  Implement Sci Commun        ISSN: 2662-2211


  71 in total

1.  Strategies to help patients understand risks.

Authors:  John Paling
Journal:  BMJ       Date:  2003-09-27

2.  Ethnic differences in access to prescription medication because of cost in New Zealand.

Authors:  Santosh Jatrana; Peter Crampton; Pauline Norris
Journal:  J Epidemiol Community Health       Date:  2010-05-12       Impact factor: 3.710

3.  Quality of hospital care for Māori patients in New Zealand: retrospective cross-sectional assessment.

Authors:  Peter Davis; Roy Lay-Yee; Lorna Dyall; Robin Briant; Andrew Sporle; Deborah Brunt; Alastair Scott
Journal:  Lancet       Date:  2006-06-10       Impact factor: 79.321

Review 4.  Breast cancer inequities between Māori and non-Māori women in Aotearoa/New Zealand.

Authors:  R Lawrenson; S Seneviratne; N Scott; T Peni; C Brown; I Campbell
Journal:  Eur J Cancer Care (Engl)       Date:  2016-03       Impact factor: 2.520

5.  Leveraging Implementation Science to Address Health Disparities in Genomic Medicine: Examples from the Field.

Authors:  Megan C Roberts; George A Mensah; Muin J Khoury
Journal:  Ethn Dis       Date:  2019-02-21       Impact factor: 1.847

6.  Attitudes toward disclosure of medication side effects: a nationwide survey of Korean patients, caregivers, and oncologists.

Authors:  Dong Wook Shin; Debra L Roter; Juhee Cho; So Young Kim; Hyung Kook Yang; Beomseok Suh; Yoon Kim; Ji-Youn Han; Ik Joo Chung; Jong-Hyock Park
Journal:  Psychooncology       Date:  2015-05-13       Impact factor: 3.894

Review 7.  Patients' understanding of risk associated with medication use: impact of European Commission guidelines and other risk scales.

Authors:  Dianne C Berry; D K Raynor; Peter Knapp; Elisabetta Bersellini
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

Review 8.  Lessons for achieving health equity comparing Aotearoa/New Zealand and the United States.

Authors:  Marshall H Chin; Paula T King; Rhys G Jones; Bryn Jones; Shanthi N Ameratunga; Naoko Muramatsu; Sarah Derrett
Journal:  Health Policy       Date:  2018-06-28       Impact factor: 2.980

9.  Patient perspectives on online health information and communication with doctors: a qualitative study of patients 50 years old and over.

Authors:  Michelle Pannor Silver
Journal:  J Med Internet Res       Date:  2015-01-13       Impact factor: 5.428

Review 10.  What types of interventions generate inequalities? Evidence from systematic reviews.

Authors:  Theo Lorenc; Mark Petticrew; Vivian Welch; Peter Tugwell
Journal:  J Epidemiol Community Health       Date:  2012-08-08       Impact factor: 3.710

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.